OABI (OmniAb) Short Interest


OABI OmniAb Inc OABI
71 GF Score
Price $2.42
GF Value $2.27
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is OmniAb Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OABI vs VNDA, AVIR, UPB: Short Interest Comparison

For the Biotechnology subindustry, OmniAb's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OmniAb Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OmniAb's Short Interest distribution charts can be found below:

* The bar in red indicates where OmniAb's Short Interest falls into.


OABI
71GF Score
OmniAb Inc OABI
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is OmniAb (OABI) Overvalued in 2026?

Based on GuruFocus' analysis, OmniAb stock appears to be overvalued. The current stock price of $2.42 is trading 6.6% above its estimated GF Value™ of $2.27. GuruFocus considers OmniAb to be Fairly Valued.

Key valuation signals for OABI:

  • Short Interest:
  • GF Value™: $2.27 vs. price of $2.42 (6.6% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the OABI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OmniAb Business Description

Address 5980 Horton Street, Suite 600, Emeryville, CA, USA, 94608
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
71GF Score

Get the complete analysis for OABI

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.42
Price
$2.27
GF Value